Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints first woman to the board

Karin Louise Dorrepaal will serve as an independent board member

Spanish pharmaceutical company Almirall has picked Karin Louise Dorrepaal to sit on its board of directors as an independent board member.

She is the first woman to join the Barcelona-based company's ten member board and has gained extensive international experience in the pharmaceutical sector during her 25 year career.

This includes six years serving as director of global business unit diagnostic imaging and supply chain and procurement at Bayer Pharma and sitting on the board of Schering for two years.

Dorrepaal currently holds non-executive positions in healthcare sector and consultancy companies.

Earlier this month, she was appointed to the supervisory board of German specialty pharma company Paion, where she replaced Grünenthal chief executive Harald Stock. 

Dorrepaal's appointment to the Almirall board will take effect from January 1, 2013, and will be ratified at the company's next annual general meeting.

23rd November 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics